How do FDA and EPA GLPs differ in the definition of raw data?

• A. They are identical except for terminology: FDA uses "nonclinical laboratory study" and EPA uses "study"
• B. They are completely different concepts
• C. FDA uses "raw data" while EPA uses "study data"
• D. EPA uses "nonclinical laboratory study" while FDA uses "study"

Answer: (A)

The main idea is that raw data under GLP is about preserving the original, unaltered records created during a study. Both FDA and EPA require these original records to exist and be traceable back to the conduct of the nonclinical work, so results can be verified. The difference lies only in wording: FDA tends to refer to the unit as a “nonclinical laboratory study,” while EPA uses the term “study.” The substance—raw data being the original observations, measurements, and records from the study—remains the same, so the definitions align in practice.